Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Deficiency (Parenthetical)

v3.5.0.2
Condensed Consolidated Statement of Changes in Stockholders' Deficiency (Parenthetical)
3 Months Ended
Mar. 31, 2016
USD ($)
Issuance of warrants $ 99,431
Series C Convertible Preferred Stock [Member]  
Gross proceeds for sale of series C convertible preferred stock 900,000
Sale of Series C convertible preferred stock, issuance costs 133,885
Sale of Series C convertible preferred stock, cash 45,000
Sale of Series C convertible preferred stock, non-cash $ 88,885